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Toxocara canis/cati are parasitic nematodes that 
resides in the small intestine of dogs, cats and wild 
carnivores. They are found worldwide. Female 
worms are approximately 10 cm long and produce 
hundreds of embrionated eggs per day. Following 
several weeks in the environment, the embryo ma-
tures to the infective larval stage within the egg. It can 
remain viable for very long periods of time. The 
prevalence of Toxocara eggs in the ground is related 
to the number of dogs in that area and climatic factors 
of the country.  
Human infection is due to accidental ingestion of 
infective eggs and tissue invasion of second stage 
Toxocara cati or canis larvae. Transmission is by con-
taminated food o by geophagia. Children up to 10 
years are more prone to be infected for both their 
common geophagia. 
Eighty per cent of pets are infested, and the in-
cidence may vary in different countries (London 33%, 
Columbus – Ohio 98%, Brisbane – Australia 100%).  
Human infection may be asymptomatic, it may 
simulate a viral infection or determine visceral larva 
migrans syndrome. The average age of onset is be-
tween 1 and 5 years and it has no correlation with 
concomitant ocular involvement. In only 2% of the 
cases of ocular toxocariasis it is possible to find a his-
tory positive for visceral larva migrans syndrome. 
The incidence of ocular toxocariasis is undeter-
mined and it may vary according to different Authors 
and in different countries. It is more frequent in chil-
dren and it constitutes 1-2% of uveitis in children. 
Toxocara should be considered as a possible causative 
agent of posterior and diffuse uveitis and always in 
the differential diagnosis of retinoblastoma. The av-
erage age at diagnosis of ocular toxocariasis is 7.5 
years (ranging from 2 to 31 years) and 80% of the pa-
tients are younger than 16 years old. [1] We can find 
three different manifestation of ocular involvement: 
chronic endophthalmitis, posterior granuloma and 
peripheral granuloma which clinical findings are re-
ported in table 1. 
 
Table 1. Clinical manifestations of ocular toxocariasis. 
  Chronic endophthalmitis  Posterior granuloma  Peripheral granuloma 
Frequency 25%  25-46%  20-40% 
Average age at onset  2-8 years  6-14 years  6-40 years 
Clinical features  Severe granulomatous vitreitis 
Cyclitic membranes 
Retinal detachment 
Leucokoria 
Strabismus 
Hypopion 
White pseudogliomatous mass at the 
posterior pole,  
Retinal folds 
Emorrhagic perilesional retinal 
detachment 
Intralesional neovascularization 
Subretinal haemorrhages 
Granuloma anterior to the equator, 
usually located temporally (90%) 
Retinal folds, vitreous tractive 
membranes  
Macular and optic nerve disversion
Retinal detachment 
Associated pars planitis 
Differential diagnosis  Retinoblastoma 
Coats’ disease 
Hyperplastic primitive vitreous 
ROP 
Toxoplasmic retinochoroiditis 
POHS 
Idiopathic subretinal neovascular 
membranes 
Congenital retinal folds 
Pars planitis 
Familiar exudative vitreoretinopa-
thy 
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The major causes of visual acuity loss are: - se-
vere vitreitis (52.6% of the cases), - cystoid macular 
edema (47,4%) and - tractional retinal detachment 
(36.8%) (Figure 1). [2] The real factors that may influ-
ence the onset of a determined clinical form are un-
known. It is possible that the lesions are due to a toxic 
or immunoallergic reaction towards larval antigens, 
mainly associated with larval death. The disruption 
occurring after larval death may determine an in-
flammatory reaction and granuloma formation. The 
associated vitreitis is usually considered a reaction 
towards highly immunogenetic antigens. The severity 
of the disease might be related to the number of the 
larvae present in the eye and by the immune response 
of the host. 
 
 
Figure 1: Ocular toxocariasis with peripheral granuloma 
and vitreoretinal traction. 
 
Diagnosis is based upon clinical features ob-
served in a young patient and should be confirmed at 
least by the presence of specific IgG in the serum 
(ELISA test, 90% specificity and 91% sensibility). 
Nevertheless the absence of specific antibodies in the 
serum does not exclude the diagnosis of ocular toxo-
cariasis and in such cases the presence of specific an-
tibodies in aqueous humor (ELISA and Gold-
mann-Witmer coefficient) demonstrate their in-
traocular production and confirm the diagnosis. [3] 
The best therapy is to prevent infection, elimi-
nating or reducing the contact between children and 
contaminated environments, periodic treatment of 
pets, in particular lactating females.  
Once the infection is established, therapy should 
be guided according to: - visual acuity, - severity of 
inflammation, - irreversible ocular damage. Generally 
peripheral granuloma are silent or show minimal in-
flammatory reaction and do not require therapy. An 
antielmintic therapy with either tiabendazole or di-
ethylcarbamazepine is not worldwide accepted be-
cause of the possibility that larvae death may increase 
the inflammatory reaction. A steroid umbrella, either 
administered sistemically or by periocular injections 
is always advisable to reduce the inflammatory reac-
tion followed by the death of the larva or given alone 
to control vitreitis and the formation of vitreoretinal 
tractional membranes. Vitreoretinal surgery is useful 
and indicated to remove vitreous opacities and 
epiretinal membranes, to prevent and to treat retinal 
detachment. Nevertheless in 24-42% of the cases a 
relapse retinal detachment may occur because of a 
persistent post-surgical inflammatory reaction. Laser 
photocoagulation has a limited role and may be used 
to kill live and mobile larva in the retinal space when 
visible (under “steroid umbrella”) and to treat chor-
oidal neovascular membrane. 
References 
1.  Nussenblatt R.B. Toxocara canis. In: Nussenblatt R.B., Whitcup 
S, Eds. Uveitis: Fundamentals and clinical practice. Philadel-
phia: Mosby. 2004: 244-249 
2.  Stewart J.M, Cubillan L.D.P, Cunningham E.T. Prevalence, 
clinical features, and causes of visual loss among patients with 
ocular toxocariasis. Retina 2005; 25:1005-1013 
3.  De Visser L, Rothova A, De Boer J.H, et al. Diagnosis of ocular 
toxocariasis by establishing intraocular antibody production. 
Am J Ophthalmol 2007; 145:369-374 
 